Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
NCT06908070
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer Stage III
Interventions
DRUG:
Consolidation durvalumab
Sponsor
Idris Bahce